Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Return on Assets %

Arbutus Biopharma Cp Return on Assets % Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Return on Assets % from 2010 to 2018.
  • Arbutus Biopharma Cp Return on Assets % for the quarter ending December 12, 2018 was -16.74 a 1.14% decrease of -0.19 year over year
  • Arbutus Biopharma Cp Return on Assets % for the last 12 months ending December 12, 2018 was -18.87 a 20.46% decrease of -3.86 year over year
  • Arbutus Biopharma Cp Annual Return on Assets % for 2018 was -18.87 a 14.66% decrease of -2.77 from 2017
  • Arbutus Biopharma Cp Annual Return on Assets % for 2017 was -16.10 a 46.35% decrease of -7.46 from 2016
  • Arbutus Biopharma Cp Annual Return on Assets % for 2016 was -8.64 a 11.04% decrease of -0.95 from 2015
Other Margins & Efficiency Metrics:
  • Arbutus Biopharma Cp EBITDA Margin for the quarter ending September 09, 2017 was $-142m a -71.85% increase of 102m year over year
  • Arbutus Biopharma Cp Return on Capital % for the quarter ending December 12, 2018 was -19.07 a -3.10% increase of 0.59 year over year
  • Arbutus Biopharma Cp Return on Equity % for the quarter ending December 12, 2018 was -35.22 a 4.57% decrease of -1.61 year over year
View Chart On Koyfin

Quarterly ABUS Return on Assets % Data

12/2018-16.74
09/2018-17.33
06/2018-17.82
03/2018-16.55
12/2017-25.11
09/2017-13.03
06/2017-18.62
03/2017-16.82
12/2016-12.28
09/2016-7.64

Annual ABUS Return on Assets % Data

2018-18.87
2017-16.10
2016-8.64
2015-7.68
2014-21.70
2013-12.22
2012-24.38
2011-38.81
2010-16.40
2009-13.11